Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Revenue

In the year 2024, Axsome Therapeutics had annual revenue of $385.69M with 42.53% growth. Axsome Therapeutics had revenue of $118.77M in the quarter ending December 31, 2024, with 66.04% growth.

• Revenue (ttm): $385.69M
• Revenue Growth: +42.53%
• P/S Ratio: 17.11
• Revenue / Employee: $707,694
• Employees: 545
• Market Cap: 6.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	385.69M	115.09M	42.53%
Dec 31, 2023	270.60M	220.56M	440.80%
Dec 31, 2022	50.04M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.